Clinical Trial Update: ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ASP-1929 Photoimmunotherapy in recurrent head and neck cancer indicates the study is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• ASP-1929 Photoimmunotherapy (ASP-1929)

Snippet

Sponsor: Rakuten Medical, Inc. | Conditions: Head and Neck Cancer, Squamous Cell Carcinoma of Head and Neck | Phase 2 | Status: ACTIVE_NOT_RECRUITING